1. Home
  2. USAS vs ZYME Comparison

USAS vs ZYME Comparison

Compare USAS & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$7.29

Market Cap

1.9B

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$24.50

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
ZYME
Founded
1998
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
USAS
ZYME
Price
$7.29
$24.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$6.50
$38.90
AVG Volume (30 Days)
5.0M
530.2K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
N/A
$105,965,000.00
Revenue This Year
$174.68
$183.10
Revenue Next Year
$53.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
38.87
52 Week Low
$0.56
$11.02
52 Week High
$10.50
$29.75

Technical Indicators

Market Signals
Indicator
USAS
ZYME
Relative Strength Index (RSI) 63.59 39.64
Support Level $6.67 $22.28
Resistance Level $8.66 $27.54
Average True Range (ATR) 0.43 1.28
MACD 0.20 -0.52
Stochastic Oscillator 89.36 17.45

Price Performance

Historical Comparison
USAS
ZYME

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: